REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

07/03/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240307:nRSG0424Ga&default-theme=true

RNS Number : 0424G  Hikma Pharmaceuticals Plc  07 March 2024

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 7 March 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons
Discharging Managerial Responsibility ("PDMR") have received shares as a
result of the vesting of their conditional share awards which were granted on
25 February 2022 under the 2014 Executive Incentive Plan ("EIP") Element B and
25 February 2021 under the EIP Element C.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities

Bassam Kanaan

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                                            Bassam Kanaan
 2   Reason for the notification
 a)  Position/status                                                                 PDMR
 b)  Initial notification /Amendment                                                 Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                                            Hikma Pharmaceuticals PLC
 b)  LEI                                                                             549300BNS685UXH4JI75
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument and identification  Description: Ordinary shares of 10 pence each (Shares)
     code

                                                                                     ID Code: GB00B0LCW083
 b)  Nature of the transaction                                                       Shares acquired from the vesting of conditional awards under the EIP Element B
                                                                                     and EIP Element C.

                                                                                     All Shares were retained.
 c)  Price(s) and volume(s)                                                          Price(s)                                  Volume(s)
     Nil                                                                                                                       EIP Award, Element B: 20,588
     Nil                                                                                                                       EIP Award, Element C: 13,378
 d)  Aggregated information                                                          Price(s): nil

                                                                                     Volume(s): 33,966
 e)  Date of the transaction                                                          6 March 2024
 f)  Place of the transaction                                                        London Stock Exchange (XLON)

 

Julie Hill

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                                             Julie Hill
 2   Reason for the notification
 a)  Position/status                                                                  PDMR
 b)  Initial notification /Amendment                                                  Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                                             Hikma Pharmaceuticals PLC
 b)  LEI                                                                              549300BNS685UXH4JI75
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument and identification   Description: Ordinary shares of 10 pence each (Shares)
     code

                                                                                      ID Code: GB00B0LCW083
 b)  Nature of the transaction                                                       Shares acquired from the vesting of conditional awards under the EIP Element
                                                                                     B.
 c)  Price(s) and volume(s)                                                          Price(s)                                  Volume(s)
     Nil                                                                                                                       5,339
 d)  Aggregated information                                                          Price(s): nil

                                                                                     Volume(s): 5,339

 e)  Date of the transaction                                                          6 March 2024
 f)  Place of the transaction                                                         London Stock Exchange (XLON)
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument and identification   Description: Ordinary shares of 10 pence each (Shares)
     code

                                                                                      ID Code: GB00B0LCW083
 b)  Nature of the transaction                                                       Shares sold to cover tax following the vesting of conditional awards under the
                                                                                     EIP Element B.
 c)  Price(s) and volume(s)                                                          Price(s)                                  Volume(s)
     £19.275                                                                                                                   2,190
 d)  Aggregated information                                                          Price(s): £19.275

                                                                                     Volume(s): 2,190

                                                                                     Total(s): £42,211.36

 e)  Date of the transaction                                                          6 March 2024
 f)  Place of the transaction                                                         London Stock Exchange (XLON)

 

 

Helen Middlemist

Group Company Secretary

+44 (0)20 7399 2760

 

7 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBXGDXBUGDGSR